U.S. Markets open in 4 hrs 54 mins

Boston Scientific’s Valuations and Price Performance

Kenneth Smith
Boston Scientific’s Valuations and Price Performance

Boston Scientific’s (BSX) enterprise value is $45.1 billion, and its enterprise-value-to-revenue ratio is 4.98x. The stock is trading at a forward PE multiple of 21.86x, which is expected to have a five-year growth multiple of 2.13x. Its price-to-sales ratio is 5.23x, and its price-to-book ratio is 6.72x. Its enterprise-value-to-EBITDA ratio is 18.5x.